华兰疫苗

301207 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

11.5B ($1.7B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

1.1B

Net Income

206.0M

Gross Margin

N/A

Op. Margin

19.1%

Net Margin

18.3%

ROE

3.4%

ROA

2.7%

D/E

0.25

Dividend Yield

N/A

EPS

0.34

Current Ratio

3.40

Price History

Company Info

Industry	C27医药制造业
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Hualan Biological Vaccine Inc. engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China. The company offers influenza vaccine (split virion), recombinant hepatitis B vaccine (hansenula polymorpha), meningococcal polysaccharide vaccine, influenza vaccine (split virion) quadrivalent, and meningococcal polysaccharide vaccine. It also sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 华兰疫苗

Ticker	301207
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业